$CANF 🚀 +47% PM 🔹 Can-Fite BioPharma is a clinical-stage biotech developing oral therapies for cancer, liver disease, and inflammatory conditions 🧬 🔹 Fresh

$CANF 🚀 +47% PM 🔹 Can-Fite BioPharma is a clinical-stage biotech developing oral therapies for cancer, liver disease, and inflammatory conditions 🧬 🔹 Fresh stock news has this one surging premarket 📈 🔹 Biotech microcaps can move fast when catalysts and volume align ⚡ 🔹 Small float + headline …